Castle Biosciences, Inc. (CSTL)

USD 26.52

(-5.76%)

Gross Profit Summary of Castle Biosciences, Inc.

  • Castle Biosciences, Inc.'s latest annual gross profit in 2023 was 174.8 Million USD , up 56.37% from previous year.
  • Castle Biosciences, Inc.'s latest quarterly gross profit in 2024 Q2 was 69.77 Million USD , up 23.72% from previous quarter.
  • Castle Biosciences, Inc. reported a annual gross profit of 105.03 Million USD in annual gross profit 2022, up 34.2% from previous year.
  • Castle Biosciences, Inc. reported a annual gross profit of 78.26 Million USD in annual gross profit 2021, up 47.77% from previous year.
  • Castle Biosciences, Inc. reported a quarterly gross profit of 69.77 Million USD for 2024 Q2, up 23.72% from previous quarter.
  • Castle Biosciences, Inc. reported a quarterly gross profit of 56.39 Million USD for 2024 Q1, up 10.52% from previous quarter.

Annual Gross Profit Chart of Castle Biosciences, Inc. (2023 - 2017)

Historical Annual Gross Profit of Castle Biosciences, Inc. (2023 - 2017)

Year Gross Profit Gross Profit Growth
2023 174.8 Million USD 56.37%
2022 105.03 Million USD 34.2%
2021 78.26 Million USD 47.77%
2020 52.96 Million USD 18.87%
2019 44.55 Million USD 154.76%
2018 17.48 Million USD 98.02%
2017 8.83 Million USD 0.0%

Peer Gross Profit Comparison of Castle Biosciences, Inc.

Name Gross Profit Gross Profit Difference
Bionano Genomics, Inc. 9.56 Million USD -1727.368%
Prenetics Global Limited 8.82 Million USD -1879.708%
Star Equity Holdings, Inc. 11.92 Million USD -1365.755%
CareDx, Inc 178.32 Million USD 1.973%
Exact Sciences Corporation 1.84 Billion USD 90.528%
Exagen Inc. 29.45 Million USD -493.448%
Inotiv, Inc. 165.44 Million USD -5.659%
Guardant Health, Inc. 336.89 Million USD 48.113%
Biodesix, Inc. 36.07 Million USD -384.536%
BioNexus Gene Lab Corp. 1.32 Million USD -13048.271%
Precipio, Inc. 6.01 Million USD -2804.719%
iSpecimen Inc. 5.1 Million USD -3322.257%
Natera, Inc. 492.74 Million USD 64.524%
Aspira Women's Health Inc. 5.26 Million USD -3222.045%
Standard BioTools Inc. 50.45 Million USD -246.494%
23andMe Holding Co. 99.37 Million USD -75.902%
Personalis, Inc. 18.2 Million USD -860.051%
Aclaris Therapeutics, Inc. 13.16 Million USD -1227.506%
Applied DNA Sciences, Inc. 5.53 Million USD -3059.088%
OpGen, Inc. -90.69 Thousand USD 192842.629%
T2 Biosystems, Inc. -8.17 Million USD 2239.608%
Myriad Genetics, Inc. 476.4 Million USD 63.307%
ICON Public Limited Company 1.81 Billion USD 90.365%
NeoGenomics, Inc. 244.6 Million USD 28.535%
Star Equity Holdings, Inc. 11.92 Million USD -1365.755%
IDEXX Laboratories, Inc. 2.18 Billion USD 92.018%
RadNet, Inc. 93 Million USD -87.963%
MDxHealth SA 43.92 Million USD -297.928%
Psychemedics Corporation 8.41 Million USD -1977.808%
Illumina, Inc. 2.74 Billion USD 93.63%
Check-Cap Ltd. -212 Thousand USD 82555.66%
Twist Bioscience Corporation 133.34 Million USD -31.089%
DarioHealth Corp. 5.98 Million USD -2821.223%
Fulgent Genetics, Inc. 104.45 Million USD -67.349%
Sera Prognostics, Inc. 96 Thousand USD -181989.583%
ENDRA Life Sciences Inc. -275.45 Thousand USD 63561.741%
OPKO Health, Inc. 318.12 Million USD 45.052%
Medpace Holdings, Inc. 524.5 Million USD 66.672%
Neogen Corporation 463.9 Million USD 62.318%
Intelligent Bio Solutions Inc. 1.42 Million USD -12161.701%
Prenetics Global Limited 8.82 Million USD -1879.708%
Mainz Biomed B.V. 509.65 Thousand USD -34198.619%
bioAffinity Technologies, Inc. 791.61 Thousand USD -21982.199%
Trinity Biotech plc 19.45 Million USD -798.746%
Neuronetics, Inc. 51.7 Million USD -238.083%
Sotera Health Company 577.15 Million USD 69.713%
bioAffinity Technologies, Inc. 791.61 Thousand USD -21982.199%